"New Drug Could Hold Promise for Alopecia"

Mount Sinai to Receive $5 Million Gift From the Asness Family to Advance Eczema and Allergy Research and Treatment

Mount Sinai Dermatologists Use Tape Strips to Map Immune Changes in Common Skin Disease

Mount Sinai Study Finds Long-Term Eczema Treatment Benefits Patients With Delayed Response

Mount Sinai Dermatologists Show Promising Results Using Combination Therapy for Vitiligo Patients

Mount Sinai Experts Author Landmark ‘Seminar’ on Atopic Dermatitis (Eczema) in The Lancet

‘Follow the science and follow your gut’ to make a change in medicine

Mount Sinai Secures Over $4 Million Grant From National Institutes of Health to Study Alopecia Areata and Atopic Dermatitis in People With Down Syndrome

Doctor Says Possible Solution for Alopecia in Children Could Be a Game-changer

Emma Guttman-Yassky, MD, PhD, Receives High Honor at European Academy of Allergy and Clinical Immunology

NIH awards Mount Sinai $6.6 million to research dupilumab as pediatric alopecia treatment

Mount Sinai Awarded $6.6 Million From National Institutes of Health to Investigate Treatment for Alopecia Areata in Children